SPHK1 and neoplasm: Patients were separated in two groups according to the proportion of tumor cells positive for SPHK1 mRNA (Low SPHK1: ≤ 50% tumor cells positive and High SPHK1: > 50% tumor cells positive) (Fig. 1b).